Skip to main content

Peer Review reports

From: Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study

Original Submission
3 May 2021 Submitted Original manuscript
23 May 2021 Author responded Author comments - Oksana Vladimirovna Stanevich
Resubmission - Version 2
23 May 2021 Submitted Manuscript version 2
5 Jul 2021 Reviewed Reviewer Report
12 Jul 2021 Reviewed Reviewer Report
3 Aug 2021 Author responded Author comments - Oksana Vladimirovna Stanevich
Resubmission - Version 3
3 Aug 2021 Submitted Manuscript version 3
23 Aug 2021 Reviewed Reviewer Report
14 Sep 2021 Author responded Author comments - Oksana Vladimirovna Stanevich
Resubmission - Version 4
14 Sep 2021 Submitted Manuscript version 4
14 Nov 2021 Reviewed Reviewer Report
11 Dec 2021 Author responded Author comments - Oksana Vladimirovna Stanevich
Resubmission - Version 5
11 Dec 2021 Submitted Manuscript version 5
13 Dec 2021 Author responded Author comments - Oksana Vladimirovna Stanevich
Resubmission - Version 6
13 Dec 2021 Submitted Manuscript version 6
Publishing
15 Dec 2021 Editorially accepted
22 Dec 2021 Article published 10.1186/s12879-021-06982-z

You can find further information about peer review here.

Back to article page